Atlas Trials

GigaGen, Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GigaGen, Inc.

RecordFirmDate
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection (NCT07024641)GigaGen, Inc.2024-11-13
A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies (NCT06258304)GigaGen, Inc.2024-05-08
Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients (NCT04883138)GigaGen, Inc.2021-05-24

Track GigaGen, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.